PUBLICATIONS

Here are our publications
emofilia-a
HEMOPHILIA A
Extended half-life RFVIII for the treatment of Hemophilia A: drugs consumption and patients’ perspective.
Daniela Paola Roggeri, Ezio Zanon, Chiara Biasoli, Alessandro Roggeri. Health Economics And Therapeutic Pathways 2020; 21(1): 59-67.
nefrologia
NEPHROLOGY
Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs.
Roggeri A, Conte F, Rossi C, Cozzolino M, Zocchetti C, Roggeri DP. Drugs In Context 2020; 9: 2020-1-1.
nefrologia
NEPHROLOGY-TRANSPLANTS
Real-world data on healthcare resource consumption and costs before and after kidney transplantation.
Roggeri DP, Roggeri A, Zocchetti C, Cozzolino M, Rossi C, Conte F. Clin Transplant. 2019 Oct;33(10):e13728.
diabete
DIABETES
Optimization of treatment with exenatide once weekly versus basal insulins for patients with type 2 diabetes: a budget impact analysis.
Roggeri A, Nicolucci A and Roggeri DP. SM J Clin Med. 2018; 4(2): 1036s.
malattie-respiratorie
RESPIRATORY DISEASES
The clinical and organizational impact of chronic respiratory diseases: what future for pulmonology?
C. Micheletto, A. Roggeri, D.P. Roggeri e F. De Michele. Rassegna di Patologia dell’Apparato Respiratorio. 2017; 32: 202-209.
gastroenterologia
GASTROENTEROLOGY
Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in italy.
Roggeri DP and Roggeri A. Hepatic Medicine: Evidence and Research 2017:9 37–43. doi: 10.2147/HMER.S146438. eCollection 2017.
emofilia-a
HEMOPHILIA A
Recently approved recombinant factor VIII (rfVIII) for the replacement treatment in patients with hemophilia A in Italy.
Roggeri DP, Zanon E, Roggeri A. Farmeconomia. Health Economics and Therapeutic Pathways 2017; 18(1): 55-60
malattie-respiratorie
RESPIRATORY DISEASES
Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study.
Roggeri DP, Roggeri A, Rossi E, Cataudella S, Martini N. Clinicoecon Outcomes Res. 2016 Aug 4;8:407-12. doi: HTTP://DX.DOI.ORG/10.2147/CEOR.S111535. eCollection 2016.
emofilia-a
HEMOPHILIA A
Kovaltry® for the replacement therapy in patients with Hemophilia
A. Roggeri DP, Colombo A, Roggeri A. Farmaeconomia, health economis and therapeutic pathways. Vol 17, No 2 (2016).
nefrologia
NEPHROLOGY
Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.
Roggeri A, Roggeri DP, Zocchetti C, Bersani M, Conte F; ReNe (Renal Lombardy Network); Additional contributors from ReNe Network. J Nephrol. 2017 Apr;30(2):263-269.. doi: 10.1007/s40620-016-0291-8. Epub 2016 May 10.
malattie-respiratorie
RESPIRATORY DISEASES
Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues.
Roggeri A , Micheletto C , Roggeri DP. Int J Chron Obstruct Pulmon Dis. 2016 Mar 21;11:597-602. doi: 10.2147/COPD.S103335. eCollection 2016.
nefrologia
NEPHROLOGY
End-stage Renal Disease Costs for Patients New to Hemodialysis in Italy: The FARO-2 Study.
Roggeri DP, Roggeri A, Brancaccio D, Mazzaferro S, Messa P, Paoletti E, Possidoni A, Costanzo AM, di Luzio Paparatti U, Cozzolino M and On behalf of the FARO-2 Study Group. British Journal of Medicine and Medical Research, ISSN: 2231-0614,Vol. 12, Issue. 5
nefrologia
NEPHROLOGY
Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study.
Roggeri DP, Cozzolino M, Mazzaferro S, Brancaccio D, Paoletti E, Roggeri A, Costanzo AM, di Luzio Paparatti U, Festa V, Messa P. Int J Nephrol Renovasc Dis. 2014 Dec 16;8:1-6. doi: 10.2147/IJNRD.S72011. eCollection 2015.
gastroenterologia
GASTROENTEROLOGY
Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs.
Roggeri DP, Roggeri A, Rossi E, Cinconze E, Gasbarrini A, Monici Preti P, De Rosa M. Hepat Med. 2015 Jul 13;7:37-42. doi: 2147/HMER.S87594. eCollection 2015.
nefrologia
NEPHROLOGY
Health economic evaluation of paricalcitol® versus cinacalcet + calcitriol (oral) in Italy.
Nuijten M, Roggeri DP, Roggeri A, Novelli P, Marshall TS. Clin Drug Investig. 2015 Apr;35(4):229-38. doi: 10.1007/s40261-014-0264-4
malattie-cardiovascolari2
CARDIOVASCULAR DISEASES
Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy.
Roggeri DP, Roggeri A, Pengo V, Farmaeconomia, health economis and therapeutic pathways 2014, 15(4) 113-127. HTTP://DX.DOI.ORG/10.7175/FE.V15I4.968
nefrologia
NEPHROLOGY
Chronic Kidney Disease: Evolution Of healthcare Costs And Resource Consumption From Predialysis To Dialysis In Piedmont Region, Italy.
Daniela Paola Roggeri, Alessandro Roggeri and Mario Salomone. Advances In Nephrology, Vol. 2014, article ID 680737, 6 pages, 2014. DOI:10.1155/2014/680737
cardiologia
CARDIOLOGY
Gender, socioeconomic position, revascularization procedures and mortality in patients presenting with stemi and nstemi in the era of primary PCI. Differences or inequities?
Roberto Gnavi, Raffaella Rusciani, Marco Dalmasso, Massimo Giammaria, Monica Anselmino, Daniela Paola Roggeri and Alessandro Roggeri. International Journal of Cardiology 176 (2014) 724–730, http://dx.doi.org/10.1016/j.ijcard.2014.07.107
malattie-respiratorie
RESPIRATORY DISEASES
Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the italian perspective of the pathos study.
Alessandro Roggeri, Claudio Micheletto and Daniela Paola Roggeri. International Journal of Chronic Obstructive Pulmonary Disease. 2014:9 569–576
cardiologia
CARDIOLOGY
Resource consumption and healthcare costs of acute coronary syndrome: a retrospective observational administrative database analysis.
Alessandro Roggeri, Roberto Gnavi, Marco Dalmasso, Raffaella Rusciani, Massimo Giammaria, Monica Anselmino and Daniela Paola Roggeri. Crit Pathw Cardiol. 2013 dec;12(4):204-9. doi: 10.1097/hpc.0b013e3182a78c06.
cardiologia
CARDIOLOGY
Outcomes, health costs and use of antiplatelet agents in 7082 patients admitted for an Acute Coronary Syndrome occurring in a large community setting.
AP Maggioni, E Rossi, E Cinconze, DP Roggeri, A Roggeri, A Fabbri and M De Rosa, on the behalf of the ARNO Cardiovascular Observatory. Cardiovascular Drugs and Therapy , March 2013 DOI:10.1007/s10557-013-6455-z
sclerosi_multipla
MULTIPLE SCLEROSIS
Use of administrative databases for the detection of resource consumption and expenditure for patients with multiple sclerosis in the Piedmont Region.
Roggeri, D.P., Roggeri, A. & Jommi, C. Pharmacoeconomics-Ital-Res-Articles 14, 79–89 (2012). https://doi.org/10.1007/BF03337456
nefrologia
NEPHROLOGY
Kidney disease and its complications: path to early diagnosis and multidisciplinary management.
G Annoni, D. Brancaccio, R. Coppo, M.G. Cozzolino, C. Cricelli, F. Fedele, DP. Roggeri, R Trevisan. Italian health Policy Brief. Ottobre 2012.
cardiologia
CARDIOLOGY
Outcomes intraospedalieri, consumption of health care resources and costs for the treatment of patients with acute coronary syndrome.
DP. Roggeri, A. Roggeri, E. Rossi. E. Cinconze. Cardiolink maggio 2012.
malattie-respiratorie
RESPIRATORY DISEASES
Palivizumab in the prophylaxis of respiratory syncytial virus: impact analysis on the Italian NHS budget.
DP. Roggeri Farmeconomia e Percorsi Terapeutici; 2011;12 (suppl.3): 17-23
dolore
Painless
Analysis of the use of strong opioids in Italy.
DP. Roggeri. NEW BIFE il consumo dei farmaci analgesici in Italia.
infettivologia
INFECTIOUS DISEASE
HIV / AIDS: evolution in the mix of resource consumption and treatment costs.
DP Roggeri. Focus On Farmacoeconomia 2009. .
dolore
Painless
Consumption and costs of drugs borne by the National Health Service for the treatment of cancer pain.
D. Roggeri, P Giusti, A Chinellato. Quaderni di Farmacoeconomia 05 2008.
oncologia
ONCOLOGY
Resource consumption and costs of treating pain in patients affected by cancer in a district of northeast italy.
D Roggeri, C Saramin, G Terrazzani, Zusso M, P Giusti and A Chinellato. Pharmacological Reasearch 56: 329-334, 2007. DOI: 10.1016/j.phrs.2007.08.001
malattie-cardiovascolari2
CARDIOVASCULAR DISEASES
Comparison of Fluvastatin + Fenofibrate combination therapy and Fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 Mellitus diabetes, and coronary heart disease: a twelve month, randomized, double-blind, controlled trial.
G. Derosa, A.F.G. Cicero, G. Bertone, M. Piccinini, L. Ciccarelli, D.P. Roggeri, R. Fogari. Clinical Therapeutics 26:8, 2004. DOI: 10.1016/j.clinthera.2004.10.008
dolore
Painless
The costs of pain medication: opioid drugs and new consumption indicators.
D Roggeri; Il Sole 24 Ore Sanità 29/06/2004.
dolore
Painless
The costs of chronic / recurrent pain in general practice.
L. Garattini, V. Caimi,S. Cipriani, D. Roggeri, D. Lanzeni, C. Viscarra e Gruppo di Studio PaCo. Pharmacoeconomics Italian Research Articles 5(3): 21-28, 2003
reumatologia
RHEUMATOLOGY
Cost analysis of celecoxib therapy vs traditional NSAIDs in osteoarthritis, in Italy.
C. Lucioni, S. Chiroli, D. Roggeri, G. Annoni. Pharmacoeconomics Italian Research Articles 5(1): 23-34, 2003
dolore
Painless – GASTROENTEROLOGY
Consumption of resources and costs for the diagnosis and treatment of gastrointestinal adverse events due to the use of Non Steroidal Anti-inflammatory Drugs (FANS): retrospective study conducted among general practitioners.
S. Chiroli, D. Roggeri. Pharmacoeconomics Italian Research Articles 3(2): 61-70,2001.
Back to home